Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Maria Lina Tornesello, Luigi Buonaguro & Franco M Buonaguro. (2015) An overview of new biomolecular pathways in pathogen-related cancers. Future Oncology 11:11, pages 1625-1639.
Read now
Read now
Masaaki Kodama, Kazunari Murakami, Tadayoshi Okimoto, Hisanori Abe, Ryugo Sato, Ryo Ogawa, Kazuhiro Mizukami, Seiji Shiota, Yoshifumi Nakagawa, Wataru Soma, Tsuyoshi Arita & Toshio Fujioka. (2013) Histological characteristics of gastric mucosa prior to Helicobacter pylori eradication may predict gastric cancer. Scandinavian Journal of Gastroenterology 48:11, pages 1249-1256.
Read now
Read now
Articles from other publishers (22)
Satoshi Imai, Takuya Ooki, Naoko Murata-Kamiya, Daisuke Komura, Kamrunnesa Tahmina, Weida Wu, Atsushi Takahashi-Kanemitsu, Christopher Takaya Knight, Akiko Kunita, Nobumi Suzuki, Adriana A. Del Valle, Mayo Tsuboi, Masahiro Hata, Yoku Hayakawa, Naomi Ohnishi, Koji Ueda, Masashi Fukayama, Tetsuo Ushiku, Shumpei Ishikawa & Masanori Hatakeyama. (2021) Helicobacter pylori CagA elicits BRCAness to induce genome instability that may underlie bacterial gastric carcinogenesis. Cell Host & Microbe 29:6, pages 941-958.e10.
Crossref
Crossref
Atsushi Takahashi-Kanemitsu, Christopher T. Knight & Masanori Hatakeyama. (2019) Molecular anatomy and pathogenic actions of Helicobacter pylori CagA that underpin gastric carcinogenesis. Cellular & Molecular Immunology 17:1, pages 50-63.
Crossref
Crossref
Souvik Ghatak, Payel Chakraborty, Subbarayan Sarathbabu, Jeremy L. Pautu, John Zohmingthanga, C. Lalchhandama & Nachimuthu Senthil Kumar. (2018) Influence of TP53 gene somatic mutations in Helicobacter pylori infected gastric tumor. Meta Gene 17, pages 108-114.
Crossref
Crossref
A. V. Belkovets, S. A. Kurilovich, V. N. Maksimov, Yu. I. Ragino, L. V. Scherbakova, O. V. Cheremisina, N. V. Cherdyntseva, M. V. Parulikova & M. I. Voevoda. (2018) POLYMORPHISM OF THE TP53 GENE IN PATIENTS WITH GASTRIC CANCER IN PROSPECTIVE AND CLINICAL CASE-CONTROL STUDIES. Siberian journal of oncology 17:3, pages 41-50.
Crossref
Crossref
Koji Ando, Eiji Oki, Hiroshi Saeki, Zhao Yan, Yasuo Tsuda, Gen Hidaka, Yuta Kasagi, Hajime Otsu, Hiroyuki Kawano, Hiroyuki Kitao, Masaru Morita & Yoshihiko Maehara. (2014) Discrimination of p53 immunohistochemistry‐positive tumors by its staining pattern in gastric cancer. Cancer Medicine 4:1, pages 75-83.
Crossref
Crossref
Masanori Hatakeyama. (2014) Helicobacter pylori CagA and Gastric Cancer: A Paradigm for Hit-and-Run Carcinogenesis. Cell Host & Microbe 15:3, pages 306-316.
Crossref
Crossref
Zhen Yang, Xu Shu, Lian Chen, Jiang Chen, Yong Xie & Nong-Hua Lu. (2012) Expression of p53-MDM2 feedback loop related proteins in different gastric pathologies in relation to Helicobacter pylori infection: Implications in gastric carcinogenesis. Clinics and Research in Hepatology and Gastroenterology 36:3, pages 235-243.
Crossref
Crossref
Juan-Bosco Lopez-Saez, Victoria Gómez-Biondi, Germán Santamaría-Rodriguez, Margarita Dominguez-Villar, Antonio Amaya-Vidal, Antonio Lorenzo-Peñuelas & Avelino Senra-Varela. (2010) Concurrent overexpression of serum p53 mutation related with Helicobacter pylori infection. Journal of Experimental & Clinical Cancer Research 29:1.
Crossref
Crossref
E. V. Elistratova, P. P. Laktionov, P. I. Shelestuk, S. A. Tuzikov, V. V. Vlassov & E. Y. Rykova. (2009) Immunochemical and molecular-Genetic markers in diagnostics of gastric cancer. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry 3:1, pages 33-43.
Crossref
Crossref
Ana Cristina Gobbo César. (2006) Genetic alterations in benign lesions: Chronic gastritis and gastric ulcer. World Journal of Gastroenterology 12:4, pages 625.
Crossref
Crossref
MASAAKI KODAMA, TOSHIO FUJIOKA, KAZUNARI MURAKAMI, TADAYOSHI OKIMOTO, RYUGO SATO, KOICHIRO WATANABE & MASARU NASU. (2005)
Eradication of
Helicobacter pylori
reduced the immunohistochemical detection of p53 and MDM2 in gastric mucosa
. Journal of Gastroenterology and Hepatology 20:6, pages 941-946.
Crossref
Crossref
L Williams, G J S Jenkins, S H Doak, P Fowler, E M Parry, T H Brown, A P Griffiths, J G Williams & J M Parry. (2005) Fluorescence in situ hybridisation analysis of chromosomal aberrations in gastric tissue: the potential involvement of Helicobacter pylori. British Journal of Cancer 92:9, pages 1759-1766.
Crossref
Crossref
Masaaki Kodama. (2005)
Helicobacter pylori-infected
animal models are extremely suitable for the investigation of gastric carcinogenesis
. World Journal of Gastroenterology 11:45, pages 7063.
Crossref
Crossref
Walid A. Mourad, Gamal El Husseiny, Mohamed Shoukri, Mohamed Rezeig, Nikolaus Chianzantoniou & Tarek Amin. (2004)
Biological markers in
Helicobacter pylori
-associated gastritis and carcinoma: the value of a scoring system
. Annals of Saudi Medicine 24:2, pages 112-118.
Crossref
Crossref
Masaaki Kodama, Kazunari Murakami, Toshio Fujioka & Akira Nishizono. (2004) Animal models for the study of Helicobacter-induced gastric carcinoma. Journal of Infection and Chemotherapy 10:6, pages 316-325.
Crossref
Crossref
Tsutomu Yoshida, Tetuo Mikami, Hiroyuki Mitomi & Isao Okayasu. (2002) Diverse p53 alterations in ulcerative colitis‐associated low‐grade dysplasia: full‐length gene sequencing in microdissected single crypts. The Journal of Pathology 199:2, pages 166-175.
Crossref
Crossref
Ming Teh, Kong Bing Tan, Bee Leng Seet & Khay Guan Yeoh. (2002)
Study of p53 immunostaining in the gastric epithelium of cagA‐positive and cagA‐negative
Helicobacter pylori
gastritis
. Cancer 95:3, pages 499-505.
Crossref
Crossref
Touta Oda, Kazunari Murakami, Akira Nishizono, Masaaki Kodama, Masaru Nasu & Toshio Fujioka. (2002)
Long‐Term
Helicobacter pylori
Infection in Japanese Monkeys Induces Atrophic Gastritis and Accumulation of Mutations in the p53 Tumor Suppressor Gene
. Helicobacter 7:3, pages 143-151.
Crossref
Crossref
Kazunari Murakami, Toshio Fujioka, Masaaki Kodama, Shoji Honda, Tadayoshi Okimoto, Touta Oda, Akira Nishizono, Ryugo Sato, Toshihiro Kubota, Jiro Kagawa & Masaru Nasu. (2002) Analysis ofp53 mutations andHelicobacter pylori infection in human and animal models. Journal of Gastroenterology 37:S13, pages 1-5.
Crossref
Crossref
Kiichi Satoh, Ken Kihira, Hiroshi Kawata, Kenkichi Tokumaru, Yasuhisa Kumakura, Yumiko Ishino, Satoshi Kawakami, Keiko Inoue, Toshichika Kojima, Yukihiro Satoh, Hiroyuki Mutoh & Kentaro Sugano. (2008)
p53 Expression in the Gastric Mucosa Before and After Eradication of
Helicobacter pylori
. Helicobacter 6:1, pages 31-36.
Crossref
Crossref
Jochen Rudi, Benedikt Bruchhausen, Dirk Kuck, Wolfgang Stremmel, Axel von Herbay, Heinrich Bauer, Martin Berger & Robert W. Owen. 2001. Biological Reactive Intermediates VI. Biological Reactive Intermediates VI
199
202
.
Gary Sisson, Jin-Yong Jeong, Avery Goodwin, Louis Bryden, Norma Rossler, Sabrina Lim-Morrison, Ausra Raudonikiene, Douglas E. Berg & Paul S. Hoffman. (2000)
Metronidazole Activation Is Mutagenic and Causes DNA Fragmentation in
Helicobacter pylori
and in
Escherichia coli
Containing a Cloned
H. pylori rdxA
+
(Nitroreductase) Gene
. Journal of Bacteriology 182:18, pages 5091-5096.
Crossref
Crossref